z-logo
open-access-imgOpen Access
Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut
Author(s) -
Michel J. van Vliet,
Wim J. E. Tissing,
Catharina A. J. Dun,
Nico E. L. Meessen,
Willem A. Kamps,
Eveline S.J.M. de Bont,
Hermie J. M. Harmsen
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/599346
Subject(s) - antibiotics , microbiology and biotechnology , antimicrobial , myeloid leukemia , feces , anaerobic bacteria , chemotherapy , medicine , bacteria , mucositis , colonization , biology , pathogenic bacteria , antimicrobial chemotherapy , immunology , genetics
Normally, humans are protected against infections by their anaerobic intestinal microorganisms providing colonization resistance. In immunocompromised patients, the endogenous intestinal gram-positive and gram-negative pathogens often cause infectious complications. Therefore, we analyzed the effect of chemotherapy treatment and antimicrobial prophylaxis on intestinal bacterial populations (microbiota) among pediatric patients with acute myeloid leukemia who are prone to intestinal mucositis and infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom